1 |
Braun J, Baraliakos X. Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis 2011;70 (Suppl 1):i97-103.
DOI
ScienceOn
|
2 |
Chiowchanwisawakit P, Lambert RG, Conner-Spady B, Maksymowych WP. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011;63:2215-2225.
DOI
ScienceOn
|
3 |
Maksymowych WP, Morency N, Conner-Spady B, Lambert RG. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis 2013;72:23-28.
DOI
ScienceOn
|
4 |
Song IH, Carrasco-Fernández J, Rudwaleit M, Sieper J. The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research. Ann Rheum Dis 2008;67:1535-1540.
DOI
|
5 |
Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-783.
DOI
ScienceOn
|
6 |
Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369: 1379-1390.
DOI
ScienceOn
|
7 |
Sieper J, van der Heijde D, Landewe R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:784-788.
DOI
ScienceOn
|
8 |
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002;61 (Suppl 3):iii8-18.
DOI
|
9 |
Edmunds L, Elswood J, Calin A. New light on uveitis in ankylosing spondylitis. J Rheumatol 1991;18:50-52.
|
10 |
Meuwissen SG, Dekker-Saeys BJ, Agenant D, Tytgat GN. Ankylosing spondylitis and inflammatory bowel disease: I. prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. Ann Rheum Dis 1978;37:30-32.
DOI
ScienceOn
|
11 |
Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 2006;20:451-471.
|
12 |
Arends S, Brouwer E, van der Veer E, et al. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study. Arthritis Res Ther 2011;13:R94.
DOI
|
13 |
Poddubnyy D, Conrad K, Ruiz-Heiland G, et al. Predictive and protective value of biomarkers in patients with ankylosing spondylitis who are at high risk of radiographic spinal progression [Abstract]. Arthritis Rheum 2011;63(Suppl 10):1338.
|
14 |
Reveille JD. The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 2006;18:332-341.
DOI
ScienceOn
|
15 |
Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68:1520-1527.
DOI
ScienceOn
|
16 |
Oh WI. HLA-B27 Subtypes in Korean Patients with Spondyloarthropathies and Healthy Controls. Seoul: Seoul National University, 1998.
|
17 |
Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-368.
DOI
ScienceOn
|